NeuroSense Therapeutics Ltd - Warrants (09/11/2026) Overview
NeuroSense Therapeutics Ltd - Warrants (09/11/2026) Discounted Cash Flow
DCF Analysis for NRSNW.
Get informed when a big investor buys or sells
+ FollowFair Value
$-0.00
Current Fair Value
$-0.00
↓ 100.2% Downside
Overvalued by 100.2% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison